Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4).
Borghi C, Ambrosioni E, Novo S, Vinereanu D, Ambrosio G; SMILE-4 Working Party. Borghi C, et al. Among authors: novo s. Clin Cardiol. 2012;35(7):416-23. doi: 10.1002/clc.22017. Epub 2012 Jun 15. Clin Cardiol. 2012. PMID: 22707187 Free PMC article. Clinical Trial.
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E; SMILE-4 Working Party. Borghi C, et al. Among authors: novo s. Cardiovasc Ther. 2016 Apr;34(2):76-84. doi: 10.1111/1755-5922.12175. Cardiovasc Ther. 2016. PMID: 26789425 Free article.
Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study.
Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E; SMILE-4 Working Party. Borghi C, et al. Among authors: novo s. J Renin Angiotensin Aldosterone Syst. 2016 Oct 5;17(4):1470320316656480. doi: 10.1177/1470320316656480. Print 2016 Oct. J Renin Angiotensin Aldosterone Syst. 2016. PMID: 27708111 Free PMC article. Clinical Trial.
Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.
Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E. Borghi C, et al. Among authors: novo s. J Cardiovasc Pharmacol. 2017 May;69(5):298-304. doi: 10.1097/FJC.0000000000000473. J Cardiovasc Pharmacol. 2017. PMID: 28195948 Free PMC article.
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4.
Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D. Borghi C, et al. Among authors: novo s. Clinicoecon Outcomes Res. 2013 Jul 8;5:317-25. doi: 10.2147/CEOR.S43138. Print 2013. Clinicoecon Outcomes Res. 2013. PMID: 23882152 Free PMC article.
Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricular ejection fraction at entry.
Borghi C, Omboni S, Cicero AF, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E. Borghi C, et al. Among authors: novo s. Open Heart. 2015 Aug 3;2(1):e000195. doi: 10.1136/openhrt-2014-000195. eCollection 2015. Open Heart. 2015. PMID: 26288740 Free PMC article.
[Undesired left ventricular pacing].
Curnis A, Bontempi L, Coppola G, Cerini M, Novo S, Dei Cas L. Curnis A, et al. Among authors: novo s. G Ital Cardiol (Rome). 2011 Nov;12(11):724-5. doi: 10.1714/966.10544. G Ital Cardiol (Rome). 2011. PMID: 22048447 Italian. No abstract available.
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Schwartz GG, et al. N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7. N Engl J Med. 2018. PMID: 30403574 Free article. Clinical Trial.
535 results